# | Title | Journal | Year | Citations |
---|
1 | Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008 | BMC Clinical Pharmacology | 2010 | 218 |
2 | Promiscuous drugs compared to selective drugs (promiscuity can be a virtue) | BMC Clinical Pharmacology | 2005 | 171 |
3 | Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005 | BMC Clinical Pharmacology | 2007 | 150 |
4 | Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations | BMC Clinical Pharmacology | 2001 | 147 |
5 | Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria | BMC Clinical Pharmacology | 2009 | 134 |
6 | Reporting of adverse drug reactions in randomised controlled trials – a systematic survey | BMC Clinical Pharmacology | 2001 | 117 |
7 | S-allylmercaptocysteine scavenges hydroxyl radical and singlet oxygen in vitro and attenuates gentamicin-induced oxidative and nitrosative stress and renal damage in vivo | BMC Clinical Pharmacology | 2004 | 110 |
8 | Knowledge, attitudes and practice survey about antimicrobial resistance and prescribing among physicians in a hospital setting in Lima, Peru | BMC Clinical Pharmacology | 2011 | 106 |
9 | Errors in medication history at hospital admission: prevalence and predicting factors | BMC Clinical Pharmacology | 2012 | 100 |
10 | Finasteride induced depression: a prospective study | BMC Clinical Pharmacology | 2006 | 98 |
11 | Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study | BMC Clinical Pharmacology | 2007 | 95 |
12 | Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls | BMC Clinical Pharmacology | 2007 | 92 |
13 | Intrathecal baclofen withdrawal syndrome- a life-threatening complication of baclofen pump: A case report | BMC Clinical Pharmacology | 2004 | 90 |
14 | Assessing Safety Culture in Pharmacies: The psychometric validation of the Safety Attitudes Questionnaire (SAQ) in a national sample of community pharmacies in Sweden | BMC Clinical Pharmacology | 2010 | 90 |
15 | Long-term platinum retention after treatment with cisplatin and oxaliplatin | BMC Clinical Pharmacology | 2008 | 86 |
16 | Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy | BMC Clinical Pharmacology | 2006 | 85 |
17 | The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty | BMC Clinical Pharmacology | 2009 | 82 |
18 | The pharmacokinetics of the interstitial space in humans | BMC Clinical Pharmacology | 2003 | 81 |
19 | Pharmacokinetics of high-dose oral thiamine hydrochloride in healthy subjects | BMC Clinical Pharmacology | 2012 | 81 |
20 | Methanol poisoning and long term sequelae – a six years follow-up after a large methanol outbreak | BMC Clinical Pharmacology | 2009 | 78 |
21 | Systematic review of dexketoprofen in acute and chronic pain | BMC Clinical Pharmacology | 2008 | 73 |
22 | Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics | BMC Clinical Pharmacology | 2009 | 73 |
23 | Single and multiple dose pharmacokinetics of maritime pine bark extract (Pycnogenol) after oral administration to healthy volunteers | BMC Clinical Pharmacology | 2006 | 65 |
24 | Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trials | BMC Clinical Pharmacology | 2010 | 63 |
25 | Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria | BMC Clinical Pharmacology | 2012 | 63 |
26 | Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3B | BMC Clinical Pharmacology | 2007 | 61 |
27 | Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people | BMC Clinical Pharmacology | 2009 | 60 |
28 | Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: The effect of water and timing of meal intake on oral delivery of Salmon Calcitonin | BMC Clinical Pharmacology | 2008 | 56 |
29 | Public perception on the role of community pharmacists in self-medication and self-care in Hong Kong | BMC Clinical Pharmacology | 2011 | 55 |
30 | Validation of an LC-MS/MS method to determine five immunosuppressants with deuterated internal standards including MPA | BMC Clinical Pharmacology | 2012 | 54 |
31 | Bioavailability of ibuprofen following oral administration of standard ibuprofen, sodium ibuprofen or ibuprofen acid incorporating poloxamer in healthy volunteers | BMC Clinical Pharmacology | 2009 | 53 |
32 | Constipation and diarrhoea - common adverse drug reactions? A cross sectional study in the general population | BMC Clinical Pharmacology | 2011 | 52 |
33 | The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903] | BMC Clinical Pharmacology | 2003 | 50 |
34 | Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro | BMC Clinical Pharmacology | 2004 | 50 |
35 | Distribution of cytochrome P450 2C, 2E1, 3A4, and 3A5 in human colon mucosa | BMC Clinical Pharmacology | 2005 | 50 |
36 | Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part B - Behavioral results | BMC Clinical Pharmacology | 2009 | 49 |
37 | Quality and safety of medication use in primary care: consensus validation of a new set of explicit medication assessment criteria and prioritisation of topics for improvement | BMC Clinical Pharmacology | 2012 | 49 |
38 | Dispensed drugs and multiple medications in the Swedish population: an individual-based register study | BMC Clinical Pharmacology | 2009 | 48 |
39 | Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs | BMC Clinical Pharmacology | 2009 | 48 |
40 | Sodium pentosan polysulfate resulted in cartilage improvement in knee osteoarthritis - An open clinical trial- | BMC Clinical Pharmacology | 2010 | 48 |
41 | Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates | BMC Clinical Pharmacology | 2011 | 48 |
42 | Population prevalence of high dose paracetamol in dispensed paracetamol/opioid prescription combinations: an observational study | BMC Clinical Pharmacology | 2012 | 48 |
43 | Pharmacokinetics of isoflavones, daidzein and genistein, after ingestion of soy beverage compared with soy extract capsules in postmenopausal Thai women | BMC Clinical Pharmacology | 2005 | 47 |
44 | Investigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitonin | BMC Clinical Pharmacology | 2008 | 46 |
45 | High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection | BMC Clinical Pharmacology | 2006 | 45 |
46 | Errors and omissions in hospital prescriptions: a survey of prescription writing in a hospital | BMC Clinical Pharmacology | 2009 | 45 |
47 | Association between statin therapy and outcomes in critically ill patients: a nested cohort study | BMC Clinical Pharmacology | 2011 | 44 |
48 | Quantitative relationship between the octanol/water partition coefficient and the diffusion limitation of the exchange between adipose and blood | BMC Clinical Pharmacology | 2010 | 42 |
49 | Appetite suppressants and valvular heart disease – a systematic review | BMC Clinical Pharmacology | 2002 | 41 |
50 | Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A - Medical results | BMC Clinical Pharmacology | 2009 | 41 |